Connection
Christine Walsh to Poly(ADP-ribose) Polymerase Inhibitors
This is a "connection" page, showing publications Christine Walsh has written about Poly(ADP-ribose) Polymerase Inhibitors.
|
|
Connection Strength |
|
 |
|
 |
|
1.552 |
|
|
|
-
Walsh C. Genetic Implications for Cancer Management: The Changing Landscape of Poly (ADP-ribose) Polymerase Inhibitor Indications in the Treatment of Ovarian Cancer. Clin Obstet Gynecol. 2024 Dec 01; 67(4):711-719.
Score: 0.852
-
Walsh C. Targeted therapy for ovarian cancer: the rapidly evolving landscape of PARP inhibitor use. Minerva Ginecol. 2018 Apr; 70(2):150-170.
Score: 0.526
-
Walsh C, Cass I. Poly(ADP-Ribose) Polymerase Inhibitors and Myeloid Neoplasm Risk-Clues to a Mechanistic Connection? JAMA Oncol. 2021 12 01; 7(12):1763-1765.
Score: 0.175